Factor XIII A subunit Val34Leu polymorphism in patients suffering atherothrombotic ischemic stroke

Thrombosis Research

Volumn 126, Issue 2, 2010, Pages 159-162

  Shemirani, Amir H ^a,b   Pongrácz, Endre ^c   Antalfi, Bálint ^d   Ádány, Róza ^a   Muszbek, László ^a,b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

^c State Health Center   (Hungary)

^d Diósgyori Vasgyári Hospital   (Hungary)

Author keywords

Cerebrovascular disease; Clinical studies; Factor XIII polymorphism; Gender; Genetic risk factors

Indexed keywords

BLOOD CLOTTING FACTOR 13A; DNA; PROTEIN VAL34LEU; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ATHEROTHROMBOTIC ISCHEMIC STROKE; BLOOD; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENETIC POLYMORPHISM; GENETIC RISK; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGE FACTORS; AGED; FACTOR XIIIA; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; SEX FACTORS; STROKE; YOUNG ADULT;

EID: 77955712510     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2010.06.012     Document Type: Article

References (45)

1. L. Muszbek, V.C. Yee, and Z. Hevessy Blood coagulation factor XIII: Structure and function Thromb Res 94 1999 271 305
2. C.S. Greenberg, D.C. Sane, and T. Lai Factor XIII and fibrin stabilization R.W. Colman, V.J. Marder, A.W. Clowes, J.N. George, S.Z. Goldhaber, Hemostasis and Thrombosis 2006 Lippincott Williams and Wilkins Philadelphia, PA 317 334
3. L. Muszbek, Z. Bagoly, Z. Bereczky, and E. Katona The involvement of blood coagulation factor XIII in fibrinolysis and thrombosis Cardiovasc Hematol Agents Med Chem 6 2008 190 205
4. H. Mikkola, M. Syrjala, V. Rasi, E. Vahtera, E. Hamalainen, and L. Peltonen Deficiency in the a-subunit of coagulation factor XIII: Two novel point mutations demonstrate different effects on transcript levels Blood 84 1994 517 525
5. L. Muszbek Deficiency causing mutations and common polymorphisms in the factor XIII-A gene Thromb Haemost 84 2000 524 527
6. H.P. Kohler, M.H. Stickland, N. Ossei-Gerning, A. Carter, H. Mikkola, and P.J. Grant Association of a common polymorphism in the factor XIII gene with myocardial infarction Thromb Haemost 79 1998 8 13
7. L. Muszbek, Z. Bereczky, Z. Bagoly, A.H. Semirani, and É. Katona Factor XIII and atherothrombotic diseases Semin Thromb Hemost 36 2010 18 33
8. Z. Voko, Z. Bereczky, E. Katona, R. Adany, and L. Muszbek Factor XIII Val34Leu variant protects against coronary artery disease. A meta-analysis Thromb Haemost 97 2007 458 463
9. A.J. Catto, H.P. Kohler, S. Bannan, M. Stickland, A. Carter, and P.J. Grant Factor XIII Val34Leu: A novel association with primary intracerebral hemorrhage Stroke 29 1998 813 816
10. J. Corral, R. Gonzalez-Conejero, J.A. Iniesta, J. Rivera, C. Martinez, and V. Vicente The fXIII val34leu polymorphism in venous and arterial thromboembolism Haematologica 85 2000 293 297
11. A. Elbaz, O. Poirier, S. Canaple, F. Chedru, F. Cambien, and P. Amarenco The association between the val34leu polymorphism in the factor XIII gene and brain infarction Blood 95 2000 586 591
12. D. Gemmati, M.L. Serino, A. Ongaro, S. Tognazzo, S. Moratelli, and R. Resca A common mutation in the gene for coagulation factor XIII-A (Val34Leu): A risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases Am J Hematol 67 2001 183 188
13. J.A. Iniesta, J. Corral, R. Gonzalez-Conejero, A. Diaz Ortuno, and M.L. Martinez Navarro Role of factor XIII Val34Leu polymorphism in patients with migraine Cephalalgia 21 2001 837 841
14. A.P. Reiner, M.B. Frank, S.M. Schwartz, M.L. Linenberger, W.T. Longstreth, and G. Teramura Coagulation factor XIII polymorphisms and the risk of myocardial infarction and ischaemic stroke in young women Br J Haematol 116 2002 376 382
15. G. Endler, M. Funk, D. Haering, W. Lalouschek, W. Lang, and M. Mirafzal Is the factor XIII 34Val/Leu polymorphism a protective factor for cerebrovascular disease? Br J Haematol 120 2003 310 314
16. K. Kain, J. Young, J. Bavington, J. Bamford, and A.J. Catto Coagulation factor XIII b subunit antigen, FXIIIVal34Leu genotype and ischaemic stroke in South Asians Thromb Haemost 93 2005 394 395
17. S. Rubattu, E. Di Angelantonio, D. Nitsch, B. Gigante, B. Zanda, and R. Stanzione Polymorphisms in prothrombotic genes and their impact on ischemic stroke in a Sardinian population Thromb Haemost 93 2005 1095 1100
18. A. Slowik, T. Dziedzic, J. Pera, D.A. Figlewicz, and A. Szczudlik Coagulation factor XIII Vai34Leu polymorphism in patients with small vessel disease or primary intracerebral hemorrhage Cerebrovasc Dis 19 2005 165 170
19. D.M. Pruissen, A.J. Slooter, F.R. Rosendaal, Y. van der Graaf, and A. Algra Coagulation factor XIII gene variation, oral contraceptives, and risk of ischemic stroke Blood 111 2008 1282 1286
20. N.L. Smith, J.C. Bis, S. Biagiotti, K. Rice, T. Lumley, and C. Kooperberg Variation in 24 hemostatic genes and associations with non-fatal myocardial infarction and ischemic stroke J Thromb Haemost 6 2008 45 53
21. Z. Bereczky, E. Balogh, E. Katona, Z. Pocsai, I. Czuriga, and G. Szeles Modulation of the risk of coronary sclerosis/myocardial infarction by the interaction between factor XIII subunit a Val34Leu polymorphism and fibrinogen concentration in the high risk hungarian population Thromb Res 120 2007 567 573
22. A.H. Shemirani, and L. Muszbek Rapid detection of the factor XIII Val34Leu (163 g- > t) polymorphism by real-time PCR using fluorescence resonance energy transfer detection and melting curve analysis Clin Chem Lab Med 42 2004 877 879
23. I. Balogh, G. Szoke, L. Karpati, U. Wartiovaara, E. Katona, and I. Komaromi Val34Leu polymorphism of plasma factor XIII: Biochemistry and epidemiology in familial thrombophilia Blood 96 2000 2479 2486
24. U. Wartiovaara, H. Mikkola, G. Szoke, G. Haramura, L. Karpati, and I. Balogh Effect of Val34Leu polymorphism on the activation of the coagulation factor XIII-A Thromb Haemost 84 2000 595 600
25. R.A. Ariens, H. Philippou, C. Nagaswami, J.W. Weisel, D.A. Lane, and P.J. Grant The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure Blood 96 2000 988 995
26. A.H. Shemirani, G. Haramura, Z. Bagoly, and L. Muszbek The combined effect of fibrin formation and factor XIII a subunit Val34Leu polymorphism on the activation of factor XIII in whole plasma Biochim Biophys Acta 1764 2006 1420 1423
27. V. Schroder, and H.P. Kohler Effect of factor XIII Val34lLeu on alpha2-antiplasmin incorporation into fibrin Thromb Haemost 84 2000 1128 1130
28. B.C. Lim, R.A. Ariens, A.M. Carter, J.W. Weisel, and P.J. Grant Genetic regulation of fibrin structure and function: Complex gene-environment interactions may modulate vascular risk Lancet 361 2003 1424 1431
29. J.P. Collet, D. Park, C. Lesty, J. Soria, C. Soria, and G. Montalescot Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: Dynamic and structural approaches by confocal microscopy Arterioscler Thromb Vasc Biol 20 2000 1354 1361
30. N. Akar, B. Donmez, and G. Deda FXIII gene Val34Leu polymorphism in Turkish children with cerebral infarct J Child Neurol 22 2007 222 224
31. J.P. Casas, A.D. Hingorani, L.E. Bautista, and P. Sharma Meta-analysis of genetic studies in ischemic stroke: Thirty-two genes involving approximately 18, 000 cases and 58, 000 controls Arch Neurol 61 2004 1652 1661
32. D.M. Pruissen, J.L. Kappelle, F.R. Rosendaal, and A. Algra Genetic association studies in ischemic stroke Cardiovasc Dis 27 2009 290 294
33. E.L. Glader, B. Stegmayr, B. Norrving, A. Terent, K. Hulter-Asberg, and P.O. Wester Sex differences in management and outcome after stroke: A Swedish national perspective Stroke 34 2003 1970 1975
34. A. Di Carlo, M. Lamassa, M. Baldereschi, G. Pracucci, A.M. Basile, and C.D. Wolfe Sex differences in the clinical presentation, resource use, and 3-month outcome of acute stroke in Europe: Data from a multicenter multinational hospital-based registry Stroke 34 2003 1114 1119
35. H.H. Vorster Fibrinogen and women's health Thromb Res 95 1999 137 154
36. W.B. Kannel, R.B. D'Agostino, P.W. Wilson, A.J. Belanger, and D.R. Gagnon Diabetes, fibrinogen, and risk of cardiovascular disease: The Framingham experience Am Heart J 120 1990 672 676
37. A. Hamsten, U. de Faire, G. Walldius, G. Dahlen, A. Szamosi, and C. Landou Plasminogen activator inhibitor in plasma: Risk factor for recurrent myocardial infarction Lancet 2 1987 3 9
38. F. Haverkate, S.G. Thompson, and F. Duckert Haemostasis factors in angina pectoris; relation to gender, age and acute-phase reaction. Results of the ECAT angina pectoris study group Thromb Haemost 73 1995 561 567
39. N. Ossei-Gerning, I.J. Wilson, and P.J. Grant Sex differences in coagulation and fibrinolysis in subjects with coronary artery disease Thromb Haemost 79 1998 736 740
40. A.H. Shemirani, E. Szomjak, Z. Csiki, E. Katona, Z. Bereczky, and L. Muszbek Elevated factor XIII level and the risk of peripheral artery disease Haematologica 93 2008 1430 1432
41. Z. Bereczky, E. Balogh, E. Katona, I. Czuriga, I. Edes, and L. Muszbek Elevated factor XIII level and the risk of myocardial infarction in women Haematologica 92 2007 287 288
42. D. Warner, M.W. Mansfield, and P.J. Grant Coagulation factor XIII and cardiovascular disease in UK Asian patients undergoing coronary angiography Thromb Haemost 85 2001 408 411 (Pubitemid 32233009)
43. H.P. Kohler, M.W. Mansfield, P.S. Clark, and P.J. Grant Interaction between insulin resistance and factor XIII Val34Leu in patients with coronary artery disease Thromb Haemost 82 1999 1202 1203
44. S.M. Boekholdt, M.S. Sandhu, N.J. Wareham, R. Luben, P.H. Reitsma, and K.T. Khaw Fibrinogen plasma levels modify the association between the factor XIII Val34Leu variant and risk of coronary artery disease: The EPIC-Norfolk prospective population study J Thromb Haemost 4 2006 2204 2209 (Pubitemid 44400299)
45. R. Gonzalez-Conejero, I. Fernandez-Cadenas, J.A. Iniesta, J. Marti-Fabregas, V. Obach, and J. Alvarez-Sabin Role of fibrinogen levels and factor XIII V34L polymorphism in thrombolytic therapy in stroke patients Stroke 37 2006 2288 2293